| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |